Symbol="VACC"
AssetType="Common Stock"
Name="Vaccitech PLC ADR"
Description="Vaccitech plc, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new T-cell vaccines and immunotherapies for the treatment and prevention of infectious diseases and cancers. The company is headquartered in Oxford, United Kingdom."
CIK="1828185"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="THE SCHRODINGER BUILDING, HEATLEY ROAD, THE OXFORD SCIENCE PARK, OXFORD, GB"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="85181000"
EBITDA="-23452000"
PERatio="None"
PEGRatio="None"
BookValue="6.19"
DividendPerShare="0"
DividendYield="0"
EPS="-0.4"
RevenuePerShareTTM="0.805"
ProfitMargin="-0.512"
OperatingMarginTTM="-0.824"
ReturnOnAssetsTTM="-0.0566"
ReturnOnEquityTTM="-0.0636"
RevenueTTM="30153000"
GrossProfitTTM="44703000"
DilutedEPSTTM="-0.4"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.969"
AnalystTargetPrice="12.33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="2.311"
PriceToBookRatio="0.359"
EVToRevenue="1.506"
EVToEBITDA="-9.07"
Beta="0.136"
num_52WeekHigh="7.45"
num_52WeekLow="2.02"
num_50DayMovingAverage="2.311"
num_200DayMovingAverage="2.503"
SharesOutstanding="38369800"
DividendDate="None"
ExDividendDate="None"
symbol="VACC"
open="2.28"
high="2.34"
low="2.12"
price="2.22"
volume="15593.00"
latest_trading_day="2023-08-07"
previous_close="2.27"
change="-0.05"
change_percent="-2.2026%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="86"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="14"
Volume_recent_avg="37444"
Change_recent_avg="-0.03"
Delta_recent_avg="0.14"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-1.15"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="14"
Aroon_momentum_negative="86"
image_negative_thumbnail_id_1="1089"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0122.jpeg"
image_negative_thumbnail_id_2="507"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0098.jpeg"
image_neutral_thumbnail_id_1="589"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0010.jpeg"
image_neutral_thumbnail_id_2="538"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0061.jpeg"
image_positive_thumbnail_id_1="692"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0016.jpeg"
image_positive_thumbnail_id_2="989"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0151.jpeg"
image_professor_thumbnail_id_1="1200"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
image_professor_thumbnail_id_2="1199"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
